Sequenom Considering Illumina, SOLiD for Down Syndrome Test; Plans to Launch LDT by End of 2011
May 18, 2010
Sequenom Considering Illumina, SOLiD for Down Syndrome Test; Plans to Launch LDT by End of 2011
Following clinical validation studies, Sequenom wants to launch a laboratory-developed test that runs on a next-generation sequencing platform by the end of 2011, and file for premarket approval by the end of the following year.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Sequenom Signs Supply Deal for T21 Test with Illumina; Firms to Collaborate on Regulatory Approval
July 12, 2011 / Clinical Sequencing News - Sequenom Runs More Than 13K T21 Tests in Q2; Plans to Expand Capacity in US and Overseas
August 1, 2012 / Clinical Sequencing News - Aria Kicks off Clinical Trial for Non-Invasive Down Syndrome Test
January 12, 2012 / GenomeWeb Daily News - Natera Sues Sequenom over Noninvasive Prenatal Diagnosis IP
January 11, 2012 / GenomeWeb Daily News - Aria Diagnostics Raises $52.7M to Commercialize Non-Invasive Trisomy Test
January 9, 2012 / GenomeWeb Daily News